Cargando…

Cardiotoxicity of immune checkpoint inhibitors

Cardiac toxicity after conventional antineoplastic drugs (eg, anthracyclines) has historically been a relevant issue. In addition, targeted therapies and biological molecules can also induce cardiotoxicity. Immune checkpoint inhibitors are a novel class of anticancer drugs, distinct from targeted or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Varricchi, Gilda, Galdiero, Maria Rosaria, Marone, Giancarlo, Criscuolo, Gjada, Triassi, Maria, Bonaduce, Domenico, Marone, Gianni, Tocchetti, Carlo Gabriele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663252/ https://www.ncbi.nlm.nih.gov/pubmed/29104763 http://dx.doi.org/10.1136/esmoopen-2017-000247

Ejemplares similares

Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events
por: Poto, Remo, et al.
Publicado: (2022)

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors
por: Pirozzi, Flora, et al.
Publicado: (2021)

Thymic Stromal Lymphopoietin Isoforms, Inflammatory Disorders, and Cancer
por: Varricchi, Gilda, et al.
Publicado: (2018)

Human Lung Mast Cells: Therapeutic Implications in Asthma
por: Poto, Remo, et al.
Publicado: (2022)

The broad spectrum of cardiotoxicities from immunotherapies
por: Iengo, Martina, et al.
Publicado: (2023)

Autoantibodies to IgE can induce the release of proinflammatory and vasoactive mediators from human cardiac mast cells
por: Poto, Remo, et al.
Publicado: (2022)

HIV gp120 Induces the Release of Proinflammatory, Angiogenic, and Lymphangiogenic Factors from Human Lung Mast Cells
por: Marone, Giancarlo, et al.
Publicado: (2020)

Bidirectional Mast Cell–Eosinophil Interactions in Inflammatory Disorders and Cancer
por: Galdiero, Maria Rosaria, et al.
Publicado: (2017)

The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition
por: Varricchi, Gilda, et al.
Publicado: (2019)

IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors
por: Cristinziano, Leonardo, et al.
Publicado: (2021)

Are Mast Cells MASTers in Cancer?
por: Varricchi, Gilda, et al.
Publicado: (2017)

The Interplay between the Immune and the Endocannabinoid Systems in Cancer
por: Braile, Mariantonia, et al.
Publicado: (2021)

Innate Immune Modulation by GM-CSF and IL-3 in Health and Disease
por: Borriello, Francesco, et al.
Publicado: (2019)

The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity
por: Afferni, Claudia, et al.
Publicado: (2018)

Potential involvement of neutrophils in human thyroid cancer
por: Galdiero, Maria Rosaria, et al.
Publicado: (2018)

Mast Cells: Fascinating but Still Elusive after 140 Years from Their Discovery
por: Varricchi, Gilda, et al.
Publicado: (2020)

Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
por: Varricchi, Gilda, et al.
Publicado: (2018)

Neutrophil Extracellular Traps, Angiogenesis and Cancer
por: Poto, Remo, et al.
Publicado: (2022)

Gender dimorphism in IgA subclasses in T2-high asthma
por: Varricchi, Gilda, et al.
Publicado: (2022)

GM-CSF and IL-3 Modulate Human Monocyte TNF-α Production and Renewal in In Vitro Models of Trained Immunity
por: Borriello, Francesco, et al.
Publicado: (2017)

Immune and Inflammatory Cells in Thyroid Cancer Microenvironment
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

Human Lung-Resident Macrophages Express and Are Targets of Thymic Stromal Lymphopoietin in the Tumor Microenvironment
por: Braile, Mariantonia, et al.
Publicado: (2021)

VEGF-A in Cardiomyocytes and Heart Diseases
por: Braile, Mariantonia, et al.
Publicado: (2020)

Human heart as a shock organ in anaphylaxis
por: Marone, Gianni, et al.
Publicado: (2014)

Cardiotoxicity of Immune Checkpoint Inhibitors
por: Patel, Rushin P., et al.
Publicado: (2021)

Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and N-Acylethanolamines in Patients with Mastocytosis
por: Ferrara, Anne Lise, et al.
Publicado: (2019)

Secreted Phospholipases A(2) in Hereditary Angioedema With C1-Inhibitor Deficiency
por: Loffredo, Stefania, et al.
Publicado: (2018)

Neutrophil extracellular traps and neutrophil-related mediators in human thyroid cancer
por: Modestino, Luca, et al.
Publicado: (2023)

Metabolic Checkpoints in Rheumatoid Arthritis
por: Pucino, Valentina, et al.
Publicado: (2020)

Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs
por: Molinaro, Marilisa, et al.
Publicado: (2015)

Cardiotoxicity from immune checkpoint inhibitors
por: Michel, Lars, et al.
Publicado: (2019)

The Potential Cardiotoxicity of Immune Checkpoint Inhibitors
por: Nardi Agmon, Inbar, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors—Associated Cardiotoxicity
por: Li, Chenghui, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors Related to Cardiotoxicity
por: Chen, Ru, et al.
Publicado: (2022)

Cardiotoxicity Associated with Immune Checkpoint Inhibitors
por: Minegishi, Shintaro, et al.
Publicado: (2023)

Future Needs in Mast Cell Biology
por: Varricchi, Gilda, et al.
Publicado: (2019)

Heterogeneity of Liver Disease in Common Variable Immunodeficiency Disorders
por: Pecoraro, Antonio, et al.
Publicado: (2020)

Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment
por: Attanasio, Umberto, et al.
Publicado: (2020)

Managing cardiotoxicity associated with immune checkpoint inhibitors
por: Upadhrasta, Sireesha, et al.
Publicado: (2019)

Cardiotoxicity risk factors with immune checkpoint inhibitors
por: Brumberger, Zachary L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_epe6476vut5bopreaidq57j13a